Ultragenyx Pharma - RARE Operatsion marja

Ultragenyx Pharma - RARE emitenti grafik logotipi

Ultragenyx Pharmaceutical (RARE) noyob patologiyalarni davolashdagi benuqson obro'ga va qimmatli olimlarni saqlab qoluvchi etik korporativ madaniyatga tayanadi. Uning strategiyasining asosida tibbiyot tomonidan e'tiborsiz qoldirilgan mutatsiyalarga qarshi kurashish uchun ishlab chiqilgan inqilobiy gen terapiyasi va mRNA usullari yotadi. Operatsion marja vaqtlar ketma-ketligi xarajatlarni boshqarishning samaradorligini tasdiqlaydi, -64.10 ko'rsatkichi esa asosiy faoliyatdan olinadigan foydaning joriy dinamikasini aks ettiradi.

Ultragenyx (RARE): Operatsion foyda normasi 04.07.2022dan 20.11.2026gacha

Ultragenyx Pharmaceutical (RARE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:ultragenyx.com, RARE
Ultragenyx Corp tayyor mahsulotlari

Ushbu ko'rsatkich aktivlarning stress-testlari paytida asosiy filtr vazifasini o'tab, moliyaviy leveraj va soliq majburiyatlari hisobga olinishidan oldin xarajatlarni boshqarish samaradorligini baholash imkonini beradi. Operatsion marja ko'rsatkichi tahlili asosiy faoliyatdan olingan foydaning tushumdagi ulushini namoyish etadi, bu esa Ultragenyx Pharmaceutical (RARE) uchun makroiqtisodiy tebranishlardan qat'i nazar, dori vositalarini tijoratlashtirishga muvaffaqiyatli o'tganini va daromadlilikning o'sishini tasdiqlaydi.

Ultragenyx Pharmaceutical raqobatchilari

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Beam Tx (BEAM) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik